We are live on !
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
(+6.8%)
Cap. Flow
+$59.9M
Cap. Flow % of AUM
Cap. Flow %
4.93%
Top 10 Holdings %
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18
Avg Time Held
Equity + Options
2.2
years
Top 10 Avg Time Held
Equity + Options
3.2
years
Top 20 Avg Time Held
Equity + Options
4
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
3.2
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$18.4M |
| 2 |
Neumora Therapeutics
NMRA
|
+$4.72M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$3.83M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$3.67M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$3.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$1.96M |
| 2 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$906K |
| 3 |
iShares International Equity Factor ETF
INTF
|
+$852K |
| 4 |
Avantis US Equity ETF
AVUS
|
+$644K |
| 5 |
Dimensional International Small Cap Value ETF
DISV
|
+$589K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.41% |
| 2 | Technology | 7.75% |
| 3 | Healthcare | 2.78% |
| 4 | Financials | 1.79% |
| 5 | Communication Services | 1.44% |
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.
- Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
- Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
- Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
- Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
- Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
- Callan Capital opened 35 new positions and closed 18 in Q2 2024.
- Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.
Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.